Notícias

Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Dow Jones and Nasdaq 100 fell below their 50-day lines as oil prices jumped. Dell, Palo Alto and Credo were earnings movers late.

Potash sales hit records as automation gains offset phosphate margin pressure.

Nutrien (NYSE:NTR) reported second-quarter adjusted EBITDA of $2.4 billion and first-half adjusted EBITDA of $3.5 billion, up 6% from a year earlier, as record potash sales volumes, proprietary-product margin growth and operating execution supported results. Cash provided by operating activities in

Moby summary of Nutrien Ltd.'s Q2 2026 earnings call

Nutrien (NTR) delivered earnings and revenue surprises of -3.33% and +1.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kenneth Seitz: Good morning, and thank you for joining us today to review our first quarter results and the outlook for our business. The ongoing Middle East conflict has disrupted global fertilizer and energy markets, resulting in higher global benchmark prices and input costs. Despite heightened geopolitical uncertainty, Nutrien's strategic priorities, capital allocation approach and full year guidance remain unchanged.

Nutrien (NYSE:NTR) reported higher first-quarter adjusted EBITDA and record potash sales volumes, while management said its full-year guidance remains unchanged despite disruptions to global fertilizer and energy markets tied to the ongoing Middle East conflict. President and CEO Ken Seitz said the

NTR beat Q1 earnings estimates as record potash volumes, stronger pricing and Retail demand lifted earnings and sales sharply year over year.

Nutrien (NTR) delivered earnings and revenue surprises of +6.99% and +12.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?